efonidipine has been researched along with nnc 55-0396 in 1 studies
| Studies (efonidipine) | Trials (efonidipine) | Recent Studies (post-2010) (efonidipine) | Studies (nnc 55-0396) | Trials (nnc 55-0396) | Recent Studies (post-2010) (nnc 55-0396) |
|---|---|---|---|---|---|
| 129 | 18 | 30 | 45 | 1 | 39 |
| Protein | Taxonomy | efonidipine (IC50) | nnc 55-0396 (IC50) |
|---|---|---|---|
| Voltage-dependent T-type calcium channel subunit alpha-1H | Homo sapiens (human) | 2 | |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CS; Kuo, CC; Pan, MK; Tai, CH; Yang, YC | 1 |
1 other study(ies) available for efonidipine and nnc 55-0396
| Article | Year |
|---|---|
Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.
Topics: Animals; Benzimidazoles; Cadmium; Calcium; Calcium Channels, T-Type; Cyclopropanes; Dihydropyridines; Disease Models, Animal; Electrophysiology; Male; Mibefradil; Movement; Naphthalenes; Neurons; Nickel; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Rats; Rats, Wistar | 2011 |